Department of Oncology, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu 211000, P.R. China.
Department of Oncology, Dafeng People's Hospital, Yancheng, Jiangsu 224000, P.R. China.
Oncol Rep. 2023 Apr;49(4). doi: 10.3892/or.2023.8516. Epub 2023 Mar 3.
MicroRNAs (miRNAs/miRs) are a group of small non‑coding RNAs that serve as post‑transcriptional gene modulators. miRNAs have been demonstrated to serve a pivotal role in carcinogenesis and the dysregulated expression of miRNAs is a well‑understood characteristic of cancer. In recent years, miR‑370 has been established as a key miRNA in various cancers. The expression of miR‑370 is dysregulated in various types of cancer and varies markedly across different tumor types. miR‑370 can regulate multiple biological processes, including cell proliferation, apoptosis, migration, invasion, as well as cell cycle progression and cell stemness. Moreover, it has been reported that miR‑370 affects the response of tumor cells to anticancer treatments. Additionally, the expression of miR‑370 is modulated by multiple factors. The present review summarizes the role and mechanism of miR‑370 in tumors, and demonstrates its potential as a molecular marker for cancer diagnosis and prognosis.
MicroRNAs (miRNAs/miRs) 是一组小的非编码 RNA,充当转录后基因调节剂。已经证明 miRNAs 在致癌作用中发挥关键作用,并且 miRNAs 的失调表达是癌症的一个众所周知的特征。近年来,miR-370 已被确定为各种癌症中的关键 miRNA。miR-370 在各种类型的癌症中的表达失调,在不同的肿瘤类型中差异显著。miR-370 可以调节多种生物学过程,包括细胞增殖、凋亡、迁移、侵袭以及细胞周期进程和细胞干性。此外,据报道,miR-370 影响肿瘤细胞对抗癌治疗的反应。此外,miR-370 的表达受多种因素调节。本综述总结了 miR-370 在肿瘤中的作用和机制,并证明其作为癌症诊断和预后的分子标志物的潜力。